Aurobindo Pharma Limited

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
21-Apr-20 Isec Unit IV receives VAI status from USFDA at last… Buy 632 770 21.8
11-Mar-20 Motilal Oswal Observations at Unit 12 resolvable on robust CAPA Buy 450 530 17.78
10-Feb-20 KR Choksey BSE Ltd (BSE) own and operate the BSE exchange platform (formerly.. Buy 542 651 20.1
22-Nov-19 Motilal Oswal Deficiency in injectables manufacturing controls Buy 429 500 16.55
14-Nov-19 KR Choksey Aurobindo reported Revenue growth of 17.9% YoY (+ 2.9% QoQ) to IN.. Buy 434 566 30.4


Analyst Calls / Meets


Management Interviews

No Management Interviews.

Investor Presentations


Annual Reports
Source: Reportjunction.com

2018-19  
2017-18  
2016-17  
2015-16  
2014-15  

Research Showcase

21-Apr-20
Isec - Company ..
Download
11-Mar-20
Motilal Oswal -..
Download
10-Feb-20
KR Choksey - Qu..
Download
22-Nov-19
Motilal Oswal -..
Download
14-Nov-19
KR Choksey - Qu..
Download

Results

06-Feb-20 Results
13-Nov-19 Results
13-Nov-19 Results
07-Aug-19 Results
28-May-19 Results Q4

AGM/EGM/Board Meetings

12-Nov-19 - Quarterly Results & In..
07-Aug-19 - Quarterly Results
28-May-19 - Audited Results
21-Mar-19 - POM
07-Feb-19 - Quarterly Results & 2n..

Press Release

04-May-20 Press Release
09-Apr-20 Press Release
02-Apr-20 Press Release
13-Nov-19 Press Release
23-Oct-19 Press Release

 

Archived Documents